October 16, 2007
Next generation IBD™ In-Line Buffer Dilution Systems from TechniKrom reduce variability, increase yields and save space in biopharmaceutical manufacturing
Press Release
Evanston, IL –TechniKrom, Inc. today announced the launch of two next generation IBDTM In-line Buffer Dilution skid systems. The new systems utilize TechniKrom’s patented Adaptive PATTM technology to enable precise and accurate in-line dilution of buffered salt solution concentrates at 300 L/hr and 1200 L/hr throughput, respectively. Buffer dilutions of up to 10-15X can be achieved with concurrent pH adjustment, offering significantly better accuracy and precision than mass flow controlled blending. TechniKrom’s Adaptive PATTM control not only provides real time adjustment of buffers based on molarity and pH but also corrects any variations in feedstock concentrate at the same time. The units can be used in any application with a high volume demand of dilute buffers, including purification, filtration, cell culture, and formulation. Engineered IBDTM systems with capacities over 6,000 L/hr are available.
July 16, 2007
TechniKrom and KNAUER Announce Alliance
Press Release
Evanston, IL –KNAUER GmbH from Berlin, Germany and TechniKrom, Inc. today announced that they have entered into an alliance agreement. TechniKrom will exclusively represent KNAUER’s larger Preparative LC and SMB equipment in the US, while KNAUER will provide sales, service and technical support for TechniKrom’s European client base.
July 9, 2007
Samchully and TechniKrom Announce Collaboration for Large Scale cGMP-Oligo Manufacturing Expansion
Press Release
Evanston, IL – Samchully Pharm. Co., Ltd. and TechniKrom, Inc. today announced that they have entered into
an exclusive supply agreement on large scale oligonucleotide manufacturing systems.
Oct 15, 2006
White Paper Alert - Kick-Starting
PAT to Achieve Quality by Design in cGMP Bioprocessing
PharmaManufacturing.com
by John Walker, VP Engineering, TechniKrom, Inc.
Since 2002, the FDA has promoted
a continuous, process-centric approach to validation
vs. the prior product–centric one. Yet, many pharma and biopharma companies
have failed to incorporate that approach into their strategic plan. This white
paper explains the new distinctions and what they mean in practice, then identifies
PAT opportunities that can be implemented immediately to support QBD activities.
Sep 15, 2006
Bioprocessing Channel: Slow
Adoption of PAT for Bioprocessing - Challenges Emanate for
Technology Development and Design of Processes
Genetic Engineering News
by Vicky Glaser
Adoption of the FDA’s Process Analytical Technology (PAT) guidance and
implementation of PAT throughout the pharma/biotech industry on the small molecule
side has been quite good, “but progress in large molecular development
has been much slower,” ...
July 2006
TechniKrom and Asahi Kasei Medical Announce Collaboration for Planova® Virus Removal Filters
Press Release
Evanston, IL - Asahi Kasei Medical Co., Ltd. and TechniKrom, Inc. today announced that they have entered into a collaborative agreement. TechniKrom will offer its bioprocess engineering, fabrication, and qualification services to supply automated viral filtration skids and Asahi Gold Particle integrity test systems to Asahi’s 1m2 and 4m2 Planova® virus removal filter end users.
July 2006
In-Line
Buffer Dilution: The "Killer
App" for Process Analytical Technology
BioProcess International, Volume:
4, Number: 7: p 66
Industry Yearbook Downstream Processing
by John Walker, VP Engineering, TechniKrom, Inc.
Biopharmaceutical companies continue to wrestle with how to approach
the implementation of Process Analytical Technology (PAT). The accelerated adoption
of many new
technologies has benefited from the identification of a "killer app" — an
early application that enables a readily achieved breakthrough in capability.
April 2006
Chromatography
roundup - We lasso the latest developments in process-scale
systems
PharmaManufacturing.com
by Paul Thomas, Managing Editor
While truly groundbreaking innovations
in chromatography equipment happen every blue moon, there
have been noteworthy gradual improvements in the areas of
chromatography media, column packing and on-line buffer blending,
say Howard Levine (president) and Tom Ransohoff (consultant)
of BioProcess Technology Consultants (Acton, Mass.).
News Archive
|
|
